CSS
CLOV icon

Cubist Systematic Strategies’s Clover Health Investments CLOV Stock Holding History

Cubist Systematic Strategies’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-90,074
Closed -$284K – 2935
2024
Q4 		$284K Sell
90,074
-211,947
-70% -$757K ﹤0.01% 2430
2024
Q3 		$852K Buy
+302,021
New +$691K 0.01% 1919
2024
Q1 		– Sell
-1,164,931
Closed -$1.11M – 3785
2023
Q4 		$1.11M Sell
1,164,931
-164,488
-12% -$162K 0.01% 1966
2023
Q3 		$1.44M Sell
1,329,419
-999,507
-43% -$1.19M 0.01% 1614
2023
Q2 		$2.09M Buy
2,328,926
+1,947,749
+511% +$1.73M 0.01% 1456
2023
Q1 		$322K Sell
381,177
-681,998
-64% -$747K ﹤0.01% 2947
2022
Q4 		$988K Buy
1,063,175
+428,944
+68% +$572K 0.01% 2464
2022
Q3 		$1.08M Buy
634,231
+365,875
+136% +$958K 0.01% 2564
2022
Q2 		$574K Sell
268,356
-1,637,769
-86% -$4.35M ﹤0.01% 2946
2022
Q1 		$6.77M Buy
1,906,125
+307,980
+19% +$893K 0.06% 516
2021
Q4 		$5.95M Buy
1,598,145
+1,523,336
+2,036% +$9.34M 0.06% 532
2021
Q3 		$553K Buy
+74,809
New +$640K 0.01% 1965
2021
Q2 		– Sell
-208,300
Closed -$1.57M – 2936
2021
Q1 		$1.57M Buy
+208,300
New +$2.35M 0.02% 1215

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Cubist Systematic Strategies's CLOV Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Clover Health Investments (CLOV) in Q1 2025, closing a stake of 90,074 shares — an estimated $284K sold.

Cubist Systematic Strategies first reported a position in CLOV in Q1 2021 and held it in 13 quarters. The position peaked at $6.77M in Q1 2022. 202 funds tracked by Wall St. Rank hold CLOV as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Clover Health Investments position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 90,074 Clover Health Investments shares in Q1 2025, an estimated $284K.
  • Cubist Systematic Strategies first reported a position in Clover Health Investments in Q1 2021 and held it in 13 quarters.
  • Cubist Systematic Strategies's Clover Health Investments position peaked at $6.77M in Q1 2022.
  • 202 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.